Clinical Trials on HPV Vaccine in Australia

Total 254 results

South Australian Health and Medical Research Institute
University of Sydney; Telethon Kids Institute; Flinders University; Royal Adelaide... and other collaborators

Recruiting

Antibiotics and Vaccine Immune Responses Study (AVIRS)

Vaccine Response Impaired

Australia
EyeGene Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

COVID-19 Vaccine

Australia
Dynavax Technologies Corporation

Completed

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers

Herpes Zoster | Vaccine-Preventable Diseases | Shingles

Australia
Bayside Health
Gilead Sciences; Centre for Clinical Research Excellence in Infectious Diseases...

Unknown

HIV-HBV Co-Infection and Liver Disease

HIV Infections | HIV-HBV Co-Infection

Australia
Aucta Pharmaceuticals, Inc

Completed

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects

HBV

Australia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
Murdoch Childrens Research Institute

Completed

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction (COSI BAIR)

COVID-19 | Vaccine Reaction | Immunization; Infection

Australia
Medical University of Vienna

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Vaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization Treatment

Austria
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 3 (HYPER3)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Clifford Craig Medical Research Trust
Johns Hopkins Bloomberg School of Public Health; Monash University; University... and other collaborators

Unknown

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Heterologous Effects of Vaccines

Australia
Pfizer

Completed

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Bacterial Infections | Staphylococcal Skin Infections | Staphylococcal Infections | Staphylococcal Vaccines | Immunotherapy, Active

Australia
The Alfred
Merck Sharp & Dohme LLC

Completed

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination (Impress)

Human Papillomavirus

Australia
Kirby Institute

Active, not recruiting

Control and Elimination Within Australia of Hepatitis C From People Living With HIV (CEASE)

Hepatitis C | HIV | HIV-HCV Coinfection

Australia
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

HIV Infections | HSV-2 Genital Herpes

Australia
Pfizer

Terminated

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation (STRIVE)

Staphylococcal Vaccine

United States, Spain, United Kingdom, Canada, France, Japan, Germany, Hungary, Austria, Bulgaria, Sweden
Kirby Institute
Government of Western Australia, Department of Health; Western Australia AIDS...

Completed

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial (PrEPIT-WA)

HIV Prevention

Australia
Medical University of Vienna

Completed

Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment

HPV

Austria
Trans Tasman Radiation Oncology Group

Active, not recruiting

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Australia, New Zealand
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS); The Alfred

Unknown

Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific

HIV Infections | HIV Related Neurological Diseases

Australia
Bayside Health
Merck Sharp & Dohme LLC

Unknown

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

HIV Positive

Australia
Bayside Health
Monash University; Austin Health; Rockefeller University; The Peter Doherty Institute... and other collaborators

Completed

Imaging the HIV Reservoir

HIV

Australia
Bayside Health
Monash University

Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Lymphoma, Non-Hodgkin | Multiple Myeloma | HIV | Chronic Lymphocytic Leukemia | Organ Transplantation | COVID-19 Vaccines

Australia
Janssen-Cilag Pty Ltd

Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

HIV-1

Australia
University of Melbourne
The Alfred; ViiV Healthcare

Completed

Dolutegravir Impact on Residual Replication (DIORR)

HIV

Australia
Holdsworth House Medical Practice

Completed

RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice

HIV Positive

Australia
St Vincent's Hospital, Sydney

Unknown

Identification and Quantification of HIV CNS Latency Biomarkers

HIV | HIV-associated Neurocognitive Disorder (HAND)

Australia
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

HIV

United Kingdom, Germany, Denmark, Belgium, Austria, Poland, Australia, Russian Federation
Holdsworth House Medical Practice
Gilead Sciences

Completed

Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia

HIV

Australia
Medical University of Vienna
Valneva Austria GmbH

Unknown

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

Japanese Encephalitis Vaccine

Austria
University of Melbourne
Johns Hopkins University; Oregon Health and Science University; University of... and other collaborators

Completed

HIV Persistence in Lymph Node and Peripheral Blood (HIV-PRADA)

HIV-1-infection

Australia
Bayside Health
The Peter Doherty Institute for Infection and Immunity

Recruiting

Optimising Cohorts for HIV Cure Interventions (HI-ART)

HIV-1-infection

Australia
Holdsworth House Medical Practice
Gilead Sciences

Completed

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia (RiC)

HIV

Australia
Holdsworth House Medical Practice
Bristol-Myers Squibb

Completed

Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia (REfLecT)

HIV

Australia
University of Sydney
The Albion Centre - South Eastern Sydney Local Health District

Unknown

Using Implementation Intentions to Increase Safe Sex Practices in MSM

HIV | Sex

Australia
Kirby Institute
Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM) and other collaborators

Recruiting

National Prisons Hepatitis Education Project: Research Evaluation (HepPEd)

HCV

Australia
Avexa

Completed

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

HIV Infection

Australia
BlueSky Immunotherapies GmbH

Enrolling by invitation

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

HPV Infection | Safety Issues

Austria
St Vincent's Hospital, Sydney
Merck Sharp & Dohme LLC

Completed

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. (ROaR+)

Cardiovascular Disease | HIV

Australia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Gilead Sciences; Hoffmann-La... and other collaborators

Terminated

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

HIV Infections | HIV-Associated Lipodystrophy

Australia
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

SPL7013 Gel - Male Tolerance Study

Human Immunodeficiency Virus (HIV)

Australia
Bayside Health

Completed

Determining the Effect of Abacavir on Platelet Activation

Cardiovascular Disease | HIV

Australia
Kirby Institute

Terminated

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients (HSCT-HIV)

HIV-1 Infection

Australia
Myrexis Inc.

Completed

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

HIV Infections

Australia
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines

Australia
St Vincent's Hospital, Sydney
Merck Sharp & Dohme LLC; The Alfred; Holdsworth House Medical Practice

Completed

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density (TROP)

HIV Infections | HIV | Osteoporosis | Osteopenia

Australia
University of Melbourne
The Alfred

Recruiting

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy (NIVO-LD)

HIV I Infection

Singapore, Australia
Bayside Health
National Institutes of Health (NIH); Monash Medical Centre

Unknown

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

HIV Infections | HIV-hepatitis Co-infection

Australia
Holdsworth House Medical Practice

Completed

Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months (CVD)

Cardiovascular Disease | HIV-1 Infection

Australia

Clinical Trials on HPV Vaccine in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations